<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28076619</article-id><article-id pub-id-type="pmc">5407147</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160086</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Oxidative Stress in Human Aorta of Patients with Advanced Aortoiliac
Occlusive Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lucas</surname><given-names>M&#x000e1;rcio Lu&#x000ed;s</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Carraro</surname><given-names>Cristina Campos</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Bell&#x000f3;-Klein</surname><given-names>Adriane</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kalil</surname><given-names>Antonio Nocchi</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Aerts</surname><given-names>Newton</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label> Santa Casa de Porto Alegre, Porto Alegre, RS,
Brazil.</aff><aff id="aff2"><label>2</label> Universidade Federal do Rio Grande do Sul (UFRGS), Porto
Alegre, RS, Brazil.</aff><aff id="aff3"><label>3</label> Universidade Federal de Ci&#x000ea;ncias da Sa&#x000fa;de
(UFCSPA), Porto Alegre, RS, Brazil.</aff><author-notes><corresp id="c1">Correspondence Address: M&#x000e1;rcio Lu&#x000ed;s Lucas, R. Prof.
Annes Dias, 295 - Centro Hist&#x000f3;rico, Porto Alegre, RS, Brazil Zip Code
90020-090. E-mail: <email>mlucasvascular@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2016</year></pub-date><volume>31</volume><issue>6</issue><fpage>428</fpage><lpage>433</lpage><history><date date-type="received"><day>25</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>30</day><month>9</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Oxidative stress seems to be a role in the atherosclerosis process, but
research in human beings is scarce.</p></sec><sec><title>Objective</title><p>To evaluate the role of oxidative stress on human aortas of patients
submitted to surgical treatment for advanced aortoiliac occlusive
disease.</p></sec><sec><title>Methods</title><p>Twenty-six patients were divided into three groups: control group (n=10)
formed by cadaveric organ donors; severe aortoiliac stenosis group (patients
with severe aortoiliac stenosis; n=9); and total aortoiliac occlusion group
(patients with chronic total aortoiliac occlusion; n=7). We evaluated the
reactive oxygen species concentration, nicotinamide adenine dinucleotide
phosphate-oxidase, superoxide dismutase and catalase activities as well as
nitrite levels in samples of aortas harvested during aortofemoral bypass for
treatment of advanced aortoiliac occlusive disease.</p></sec><sec><title>Results</title><p>We observed a higher level of reactive oxygen species in total aortoiliac
occlusion group (48.3&#x000b1;9.56 pmol/mg protein) when compared to severe
aortoiliac stenosis (33.5&#x000b1;7.4 pmol/mg protein) and control
(4.91&#x000b1;0.8 pmol/mg protein) groups (<italic>P</italic>&#x0003c;0.05).
Nicotinamide adenine dinucleotide phosphate oxidase activity was also higher
in total aortoiliac occlusion group when compared to the control group
(3.81&#x000b1;1.7 <italic>versus</italic> 1.05&#x000b1;0.31 &#x000b5;mol/min.mg
protein; <italic>P</italic>&#x0003c;0.05). Furthermore, superoxide dismutase and
catalase activities were significantly higher in the severe aortoiliac
stenosis and total aortoiliac occlusion groups when compared to the control
cases (<italic>P</italic>&#x0003c;0.05). Nitrite concentration was smaller in the
severe aortoiliac stenosis group in comparing to the other groups.</p></sec><sec><title>Conclusion</title><p>Our results indicated an increase of reactive oxygen species levels and
nicotinamide adenine dinucleotide phosphate-oxidase activity in human aortic
samples of patients with advanced aortoiliac occlusive disease. The increase
of antioxidant enzymes activities may be due to a compensative phenomenon to
reactive oxygen species production mediated by nicotinamide adenine
dinucleotide phosphate oxidase. This preliminary study offers us a more
comprehensive knowledge about the role of oxidative stress in advanced
aortoiliac occlusive disease in human beings.</p></sec></abstract><kwd-group><kwd>Oxidative Stress</kwd><kwd>Arterial Occlusive Diseases</kwd><kwd>Reactive Oxygen Species</kwd></kwd-group></article-meta></front><body><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup width="50%" span="1"><col span="1"/><col span="1"/></colgroup><thead><tr style="background-color:#e6e7e8"><th colspan="2" rowspan="1"><bold>Abbreviations, acronyms &#x00026; symbols</bold></th></tr></thead><tbody><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">AAA</td><td align="left" rowspan="1" colspan="1">= Abdominal aortic aneurysm</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">AOD</td><td align="left" rowspan="1" colspan="1">= Aortoiliac occlusive disease</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">= Body mass index</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">CAT</td><td align="left" rowspan="1" colspan="1">= Catalase</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">DCF</td><td align="left" rowspan="1" colspan="1">= 2,7-dichlorofluorescein</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">H<sub>2</sub>O<sub>2</sub></td><td align="left" rowspan="1" colspan="1">= Hydrogen peroxide</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ICU</td><td align="left" rowspan="1" colspan="1">= Intensive care unit</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">LVEF</td><td align="left" rowspan="1" colspan="1">= Left ventricular ejection fraction</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">NADPH</td><td align="left" rowspan="1" colspan="1">= Nicotinamide-adenine-dinucleotide-phosphate</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">NO</td><td align="left" rowspan="1" colspan="1">= Nitric oxide</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">NOS</td><td align="left" rowspan="1" colspan="1">= Nitric oxide synthase</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">O<sub>2</sub>-</td><td align="left" rowspan="1" colspan="1">= Superoxide anion</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">OH-</td><td align="left" rowspan="1" colspan="1">= Hydroxyl radical</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ONOO-</td><td align="left" rowspan="1" colspan="1">= Peroxynitrite</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">ROS</td><td align="left" rowspan="1" colspan="1">= Reactive oxygen species</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">SAS</td><td align="left" rowspan="1" colspan="1">= Severe aortoiliac stenosis</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">SOD</td><td align="left" rowspan="1" colspan="1">= Superoxide dismutase</td></tr><tr style="background-color:#e6e7e8"><td align="left" rowspan="1" colspan="1">TAO</td><td align="left" rowspan="1" colspan="1">= Total aortoiliac occlusion</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Aortoiliac occlusive disease (AOD) provoked by atherosclerosis is an important cause
of morbidity and mortality worldwide, which begins at the aortic terminus and common
iliac artery origins and slowly progresses proximally and distally over time,
resulting in a severe aortoiliac stenosis (SAS) or in a total aortoiliac occlusion
(TAO)<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>]</sup>.
Although advances in the endovascular techniques, aortobifemoral bypass is still the
gold standard treatment for patients with SAS and TAO<sup>[</sup><sup><xref rid="r1" ref-type="bibr">1</xref></sup><sup>,</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup>.</p><p>The cellular and molecular basis for atherosclerosis is complex and is not completely
understood<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>. It is widely accepted that oxidative stress plays
important role in the pathogenesis of atherosclerosis<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>]</sup>. Oxidative stress is
caused by an imbalance between the production of reactive oxygen species (ROS) and
the antioxidant capacity of the biological system<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>. ROS such as superoxide
anion (O<sub>2</sub><sup>-</sup>), hydroxyl radical (OH<sup>-</sup>), and hydrogen
peroxide (H<sub>2</sub>O<sub>2</sub>), are produced through different pathways, but
the major source of ROS in the vasculature is
nicotinamide-adenine-dinucleotide-phosphate (NADPH) oxidase<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>. Superoxide dismutase
(SOD) is the major cellular defense system to remove O<sub>2</sub><sup>-</sup> in
vascular cells by converting O<sub>2</sub><sup>-</sup> into
H<sub>2</sub>O<sub>2</sub>, while catalase (CAT) converts two molecules of
H<sub>2</sub>O<sub>2</sub> into water and oxygen<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>. Nitric oxide (NO) -
synthetized by nitric oxide synthase (NOS) - is a multifactorial free radical that
plays a key role in the physiological regulation of the cardiovascular system, and
changes in its production and/or bioavailability follow or even precede diseases
such as atherosclerosis<sup>[</sup><sup><xref rid="r8" ref-type="bibr">8</xref></sup><sup>]</sup>. Superoxide anion may react with NO to form
peroxynitrite (ONOO<sup>-</sup>), resulting in an increased cellular
damage<sup><xref rid="r7" ref-type="bibr">7</xref></sup>. Moreover,
inactivation of NO by O<sub>2</sub><sup>-</sup> limits the NO bioavailability
leading to increased vasoconstriction, as commonly observed in the progression of
atherosclerosis<sup>[</sup><sup><xref rid="r7" ref-type="bibr">7</xref></sup><sup>]</sup>.</p><p>Some experimental studies have investigated the role of oxidative stress in the
atherosclerosis process<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>,</sup><sup><xref rid="r9" ref-type="bibr">9</xref></sup><sup>,</sup><sup><xref rid="r10" ref-type="bibr">10</xref></sup><sup>]</sup>, but research in human beings are
rare<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>. In this study, we evaluated the role of oxidative
stress in patients's aortas whith SAS and TAO submitted to aortobifemoral bypass.
Thus, we proposed to compare the oxidative damage in different degrees of AOD in
human beings.</p></sec><sec sec-type="methods"><title>METHODS</title><p>The project was approved by the Research Ethics Committee of Santa Casa de Porto
Alegre and all patients signed free and informed consent forms. We reviewed medical
records for patients with SAS and TAO electively submitted to aortobifemoral bypass
by the first author as previously described<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>]</sup>.</p><p>All the patients were submitted to surgical procedure due to a limiting claudication
or critical limb ischemia (rest pain and/or non-healing wound). Patients with acute
aortoiliac occlusion, abdominal aortic aneurysm (AAA) thrombosis, and submitted to
previous aortoiliac intervention (endovascular or open repair) were excluded. Data
were collected on age, gender, comorbidities and clinical presentation for patients
with SAS or TAO. Laboratory profiles and surgical data were also routinely
collected. All the patients were submitted to computed tomography angiography to
plan the surgical procedures.</p><p>Human specimens of infrarenal abdominal aorta were removed in the operating room
during the proximal anastomosis of aortobifemoral bypasses. After removing the
calcifications, the aortic samples were immediately stored at -70&#x000b0;C for further
analysis of oxidative stress parameters. They were macerate in liquid nitrogen.
After that, it was homogenized (KCl 150 mmol/L; phenyl-methyl-fluoro-sulfonyl 20
mmol/L, 1:100) in the Ultra-Turrax homogenizer. Posteriorly, it was performed a
sonification with the Hielscher Ultrasound Technology device<sup>[</sup><sup><xref rid="r12" ref-type="bibr">12</xref></sup><sup>]</sup>.</p><p>ROS concentration was measured by DCFH-DA fluorescence emission (Sigma-Aldrich, USA).
Dichlorofluorescein diacetate is membrane permeable and is rapidly oxidized to the
highly fluorescent 2,7-dichlorofluorescein (DCF) in the presence of intracellular
ROS. The samples were excited at 488 nm and emission was collected with a 525 nm
long pass filter. It was expressed as nmols per milligram of
protein<sup>[</sup><sup><xref rid="r13" ref-type="bibr">13</xref></sup><sup>]</sup>.</p><p>Measurement of NADPH oxidase activity was assayed with spectrophotometric
method<sup>[</sup><sup><xref rid="r14" ref-type="bibr">14</xref></sup><sup>]</sup>. SOD activity, expressed as U/mg protein, was based
on the inhibition of superoxide radical reaction with
pyrogallol<sup>[</sup><sup><xref rid="r15" ref-type="bibr">15</xref></sup><sup>]</sup>. CAT activity was determined by following the
decrease in 240 nm absorption of hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). It
was expressed as nmoles/mg protein<sup>[</sup><sup><xref rid="r16" ref-type="bibr">16</xref></sup><sup>]</sup>. NO in aortic samples was examined by measuring
the level of nitrite, an oxidative metabolite of endogenous NO, by using the Griess
reagent, in which a chromophore with a strong absorbance at 542 nm is formed by
reaction of nitrite with a mixture of naphthyletilenediamine (0.1%) and
sulphanilamide (1%). The absorbance was measured in a spectrophotometer to give the
nitrite concentration<sup>[</sup><sup><xref rid="r17" ref-type="bibr">17</xref></sup><sup>]</sup>. Protein was measured by the method of Lowry et
al.<sup>[</sup><sup><xref rid="r18" ref-type="bibr">18</xref></sup><sup>]</sup>,
using bovine serum albumin as standard.</p><sec><title>Statistical Analysis</title><p>All data are expressed as the mean &#x000b1; standard deviation. Comparisons
between two groups were performed by Fisher's exact test and statistical
analysis for three groups included the ANOVA method followed by t test. A
statistical significance was assumed to be &#x003b1;=5%.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Twenty-six patients were divided into three groups: control group (n=10) formed by
cadaveric organ donors (aged 22 to 51 years old); SAS group (n=9) formed by patients
with SAS; and TAO group (n=7) formed by patients with chronic total aortoiliac
occlusion. The clinical and surgical data are summarized in <xref ref-type="table" rid="t1">Table 1</xref>. In each group, there were 4 women. The mean age, body
mass index (BMI), and left ventricular ejection fraction (LVEF) were similar between
the SAS and TAO groups. In relation to surgical data, there was no perioperative
death in both groups. The duration of the procedures, blood loss, and intensive care
unit (ICU) stay as well as postoperative hospital stay were also similar between the
SAS and TAO groups (<xref ref-type="table" rid="t1">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Clinical characteristics and surgical data of patients with severe aortoiliac
stenosis (SAS) and totally aortoiliac occlusion (TAO) submitted to
aortobifemoral bypass.</p></caption><table frame="hsides" rules="all"><colgroup width="25%" span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><bold>Characteristics</bold></th><th align="center" rowspan="1" colspan="1"><bold>SAS group (n=9)</bold></th><th align="center" rowspan="1" colspan="1"><bold>TAO group (n=7)</bold></th><th align="center" rowspan="1" colspan="1"><bold>P values</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Mean age (years)</td><td align="center" rowspan="1" colspan="1">57.7&#x000b1;5.86</td><td align="center" rowspan="1" colspan="1">55.1&#x000b1;5.91</td><td align="center" rowspan="1" colspan="1">0.42</td></tr><tr><td align="left" rowspan="1" colspan="1">Women n (%)</td><td align="center" rowspan="1" colspan="1">4 (44.5)</td><td align="center" rowspan="1" colspan="1">4 (57.1)</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Tobacco use (%)</td><td align="center" rowspan="1" colspan="1">9 (100)</td><td align="center" rowspan="1" colspan="1">7 (100)</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension (%)</td><td align="center" rowspan="1" colspan="1">8 (88.9)</td><td align="center" rowspan="1" colspan="1">5 (71.4)</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidemia (%)</td><td align="center" rowspan="1" colspan="1">3 (33.4)</td><td align="center" rowspan="1" colspan="1">2 (28.6)</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes (%)</td><td align="center" rowspan="1" colspan="1">2 (22.3)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.47</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">25.8&#x000b1;3.25</td><td align="center" rowspan="1" colspan="1">21.8&#x000b1;4.33</td><td align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" rowspan="1" colspan="1">LVEF (%)</td><td align="center" rowspan="1" colspan="1">60&#x000b1;2.67</td><td align="center" rowspan="1" colspan="1">67.5&#x000b1;8.01</td><td align="center" rowspan="1" colspan="1">0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">Systolic pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">131.14&#x000b1;9.96</td><td align="center" rowspan="1" colspan="1">129.3&#x000b1;14.24</td><td align="center" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" rowspan="1" colspan="1">Diastolic pressure (mmHg)</td><td align="center" rowspan="1" colspan="1">60.7&#x000b1;8.3</td><td align="center" rowspan="1" colspan="1">71.7&#x000b1;15.7</td><td align="center" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" rowspan="1" colspan="1">Creatinine (mg/dL)</td><td align="center" rowspan="1" colspan="1">0.92&#x000b1;0.14</td><td align="center" rowspan="1" colspan="1">0.94&#x000b1;0.08</td><td align="center" rowspan="1" colspan="1">0.88</td></tr><tr><td align="left" rowspan="1" colspan="1">Perioperative death</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of procedures (minutes)</td><td align="center" rowspan="1" colspan="1">269.2&#x000b1;54.34</td><td align="center" rowspan="1" colspan="1">228&#x000b1;44.9</td><td align="center" rowspan="1" colspan="1">0.25</td></tr><tr><td align="left" rowspan="1" colspan="1">Blood loss (mL)</td><td align="center" rowspan="1" colspan="1">637.5&#x000b1;316.9</td><td align="center" rowspan="1" colspan="1">614.3&#x000b1;203.3</td><td align="center" rowspan="1" colspan="1">0.87</td></tr><tr><td align="left" rowspan="1" colspan="1">Median postoperative days (range)</td><td align="center" rowspan="1" colspan="1">10.5 (7-14)</td><td align="center" rowspan="1" colspan="1">11 (6-19)</td><td align="center" rowspan="1" colspan="1">0.56</td></tr><tr><td align="left" rowspan="1" colspan="1">Median ITU stay in hours (range)</td><td align="center" rowspan="1" colspan="1">46 (28-72)</td><td align="center" rowspan="1" colspan="1">40 (30-58)</td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">Lower preoperative ABI</td><td align="center" rowspan="1" colspan="1">0.44&#x000b1;0.13</td><td align="center" rowspan="1" colspan="1">0.39&#x000b1;0.08</td><td align="center" rowspan="1" colspan="1">0.48</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative ABI</td><td align="center" rowspan="1" colspan="1">0.78&#x000b1;0.12</td><td align="center" rowspan="1" colspan="1">0.84&#x000b1;0.17</td><td align="center" rowspan="1" colspan="1">0.47</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>ABI=ankle-brachial index; BMI=body mass index; LVEF=left ventricular
ejection fraction</p></fn></table-wrap-foot></table-wrap><p>The aortic ROS levels were significantly higher in the SAS and TAO groups when
compared to the control group (<italic>P</italic>&#x0003c;0.05). Patients with TAO
demonstrated higher levels of ROS (48.3&#x000b1;10.22 pmol/mg protein) when compared
to the SAS group (33.02&#x000b1;4.54 pmol/mg protein; <italic>P</italic>&#x0003c;0.05)
(<xref ref-type="fig" rid="f1">Figure 1</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Levels of reactive oxygen species (ROS) on human aortas of patients with
severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac
occlusion (TAO). Values are expressed in mean and the brackets represent
interval of confidence of 95%. ANOVA followed test t. *P&#x0003c;0.05 when
compared to control group; and <sup>#</sup>P&#x0003c;0.05 when compared to
SAS group.</p></caption><graphic xlink:href="rbccv-31-06-0428-g01"/></fig>
</p><p>Measurement of NADPH oxidase activity demonstrated that TAO group had an increment
when compared to control group (<xref ref-type="fig" rid="f2">Figure 2</xref>).
Moreover, there was no difference in the NADPH oxidase activity between SAS and
others groups (<italic>P</italic>&#x0003e;0.05).</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>NADPH oxidase activity on human aortas of patients with severe aortoiliac
occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO).
Values are expressed in mean and the brackets represent interval of
confidence of 95%. ANOVA followed test t. *P&#x0003c;0.05 when compared to
control group..</p></caption><graphic xlink:href="rbccv-31-06-0428-g02"/></fig>
</p><p>It was observed an increase of SOD activity in the SAS and TAO groups when compared
to the control group (<italic>P</italic>&#x0003c;0.05) (<xref ref-type="fig" rid="f3">Figure 3</xref>). However, there was no statistical difference between SAS and
TAO groups. There was a significant increase of CAT activity in the SAS and TAO
groups when compared to the control group. Furthermore, CAT activity in aortas from
patients with SAS (60.2&#x000b1;9.5 pmol/mg protein) was statistically higher in
comparing to the TAO group (44.74&#x000b1;7 pmol/mg protein;
<italic>P</italic>&#x0003c;0.05) (<xref ref-type="fig" rid="f4">Figure 4</xref>).</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Superoxide dismutase (SOD) activity on human aortas of patients with
severe aortoiliac occlusive stenosis (SAS) and with total aortoiliac
occlusion (TAO). Values are expressed in mean and the brackets represent
interval of confidence of 95%. ANOVA followed test t. *P&#x0003c;0.05 when
compared to control group.</p></caption><graphic xlink:href="rbccv-31-06-0428-g03"/></fig>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Catalase (CAT) activity on human aortas of patients with severe
aortoiliac occlusive stenosis (SAS) and with total aortoiliac occlusion
(TAO). Values are expressed in mean and the brackets represent interval
of confidence of 95%. ANOVA followed test t. *P&#x0003c;0.05 when compared to
control group; <sup>#</sup>P&#x0003c;0.05 when compared to TAO group.</p></caption><graphic xlink:href="rbccv-31-06-0428-g04"/></fig>
</p><p>Nitrite levels were significantly lower in the aortic samples of patients with SAS
when compared to the other groups (<italic>P</italic>&#x0003c;0.05). Furthermore, there
was no difference in the nitrite levels between TAO and the control group
(<italic>P</italic>&#x0003e;0.05) (<xref ref-type="fig" rid="f5">Figure
5</xref>).</p><p>
<fig id="f5" orientation="portrait" position="float"><label>Fig. 5</label><caption><p>Nitrite levels on human aortas of patients with severe aortoiliac
occlusive stenosis (SAS) and with total aortoiliac occlusion (TAO).
Values are expressed in mean and the brackets represent interval of
confidence of 95%. ANOVA followed test t. *P&#x0003c;0.05 when compared to
SAS group.</p></caption><graphic xlink:href="rbccv-31-06-0428-g05"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Advanced AOD tends to occur in relatively young patients who have a history of
tobacco abuse. Basically, patients with SAS and TAO are treated by the
aortobifemoral bypass and the surgical results in these patients seems to be
similar<sup>[</sup><sup><xref rid="r2" ref-type="bibr">2</xref></sup><sup>,</sup><sup><xref rid="r19" ref-type="bibr">19</xref></sup><sup>]</sup>.</p><p>The major finding of our study was to demonstrate the role of oxidative stress in the
atherosclerosis in patients with different degrees of AOD. Our results demonstrated
that ROS levels were progressively higher as more severe as the AOD was. This way,
patients with SAS or TAO had a higher ROS levels on their aorta samples; and the TAO
group demonstrated a more elevated of ROS levels than SAS group. The role of ROS in
the onset and progression of atherosclerotic damage in aortas has been described in
animal models of different illnesses, being the ROS important mediators in the
signaling pathways of inflammation and atherogenesis<sup>[</sup><sup><xref rid="r4" ref-type="bibr">4</xref></sup><sup>,</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>. In atherosclerosis, ROS
production can increment endothelial dysfunction, vascular smooth muscle cells
proliferation and apoptosis, and inflammatory response<sup>[</sup><sup><xref rid="r20" ref-type="bibr">20</xref></sup><sup>]</sup>. Another markers of
oxidative stress, such as levels of O<sub>2</sub><sup>-</sup>, thiobarbituric acid
and conjugated dienes were also evaluated in aortic samples of patients with
atherosclerosis<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>.</p><p>Xiong et al.<sup>[</sup><sup><xref rid="r22" ref-type="bibr">22</xref></sup><sup>]</sup> demonstrated that the earliest changes in an
experimental model of AAA were associated with the local production of ROS. In the
study of Miller et al.<sup>[</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>, it was measured levels of
O<sub>2</sub><sup>-</sup> and lipid peroxidation products in segments of AAA and
in adjacent nonaneurysmal aortic tissue removed from patients undergoing elective
AAA repair. The results indicated that levels of ROS are locally increased in AAA,
partially because of NADPH oxidase activity, and lead to marked increases in
oxidative stress. There are evidences that NADPH oxidase expression and activity are
upregulated in atherosclerosis<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup>. Analysis of non-atherosclerotic
<italic>versus</italic> atherosclerotic human carotid arteries demonstrated a
higher level of NADPH oxidase expression in atherosclerotic
arteries<sup>[</sup><sup><xref rid="r23" ref-type="bibr">23</xref></sup><sup>]</sup>. We also observed an increase of NADPH oxidase
activity in patients with TAO when compared to the control group. Haidari et
al.<sup>[</sup><sup><xref rid="r3" ref-type="bibr">3</xref></sup><sup>]</sup>
observed an increase of oxidative stress in atherosclerosis-predisposed regions of
the normal C57BL/6 mouse aorta, implicating NADPH oxidase as a possible contributing
enzyme.</p><p>The imbalance between oxidants and antioxidants in favor of the former ones plays a
significant role in the pathogenesis of atherosclerotic vascular
disease<sup>[</sup><sup><xref rid="r6" ref-type="bibr">6</xref></sup><sup>]</sup>. Thus, knowledge of the activity of antioxidants
enzymes is very important. Under normal conditions, SOD is the first line of defense
against oxidative stress<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>. Dubick et al.<sup>[</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>]</sup> demonstrated a lower activity of SOD
in human aortic samples of patients with AAA and AOD in comparing to
non-atherosclerotic organ donors. In another work, the same group of authors also
compared the SOD activity between aortic specimens of patients with aneurysmal and
occlusive disease. These authors evidenced a reduced SOD activity in occlusive
(n=14) compared to aneurysmal (n=29) group<sup>[</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. In contrast, our study showed a
significant increase of SOD activity in the SAS and TAO samples when compared to the
control group, maybe because a compensative phenomenon to minimize oxidative stress.
Furthermore, the role of oxidative stress in different aortopathies was evaluated by
Soto et al.<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>. In this study, there was an increase in SOD
activity in aorta specimens of patients with hypertension, Marfan and Turner's
syndromes<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>.</p><p>Catalase is another important antioxidant enzyme, which is found in the liver,
kidney, and aorta. Catalase uses two H<sub>2</sub>O<sub>2</sub> molecules to break
them into O<sub>2</sub><sup>-</sup>; one acts as a reducing agent and the other as
an oxidant agent. Overexpression of CAT prevents the stimulation of ROS and can
prevent AAA formation in experimental setting<sup>[</sup><sup><xref rid="r26" ref-type="bibr">26</xref></sup><sup>]</sup>. Moreover, a diminished CAT expression
and activity were observed in polymorphonuclear neutrophils in patients with
AAA<sup>[</sup><sup><xref rid="r27" ref-type="bibr">27</xref></sup><sup>]</sup>.
Soto et al.<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup> also showed that CAT activity increased in the
patients with different aortopathies. Our results corroborate these findings that
the increase of CAT activity in SAS and TAO groups may be due to overproduction of
H<sub>2</sub>O<sub>2</sub> in the aorta from these patients.</p><p>NO is usually quoted for its vasodilating properties and protective role in many
vascular diseases and previous reports have indicated that decreased activity and
production of NO play an important role in vascular disease<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>. Endothelial
dysfunction and downregulated NO would contribute to the stiffness, reduced
distensibility, and aortic complications such as AOD<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>]</sup>. Our results showed a
decrease of nitrite levels in SAS group may be due to endothelium dysfunction.
Moreover, we did not observe an increase in nitrite levels in patients with TAO and
this can be explained at least in part because of the higher levels of ROS which
could increase the nitrite levels by inducible NOS activation, an enzyme which
produces high quantities of NO, resulting in more oxidative
stress<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>,</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>]</sup>. Taking together, the higher levels of ROS and
nitrite could facilitate intravascular thrombus formation by reducing the
antiplatelets effects of NO<sup>[</sup><sup><xref rid="r28" ref-type="bibr">28</xref></sup><sup>]</sup>. Then, this aortic thrombus can provoke an
inflammatory response in the aortic wall and can also limit the oxygen supply to
endothelium resulting in increasing of NO production<sup>[</sup><sup><xref rid="r29" ref-type="bibr">29</xref></sup><sup>]</sup>. Liao et
al.<sup>[</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>]</sup>
founded an overexpression of NOS which was positively correlated with the degree of
inflammation in the aortic wall in patients with AAA.</p><p>The major limitation of this study is the small size of patients and aortic samples,
preventing some correlation with clinical and angiographic findings. However,
previous studies performed with human aortic samples have also been described with
small number of samples and have obtained aortas from autopsy or organ donor
patients as control group<sup>[</sup><sup><xref rid="r5" ref-type="bibr">5</xref></sup><sup>,</sup><sup><xref rid="r11" ref-type="bibr">11</xref></sup><sup>,</sup><sup><xref rid="r21" ref-type="bibr">21</xref></sup><sup>,</sup><sup><xref rid="r24" ref-type="bibr">24</xref></sup><sup>,</sup><sup><xref rid="r25" ref-type="bibr">25</xref></sup><sup>]</sup>. To our knowledge, this is the first study in which
human aortic segments of patients with different degrees of AOD were directly
compared.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Our study on human aortic samples showed that oxidative stress seems to be related
with the degree of AOD and the increase of antioxidant enzymes (SOD and CAT)
activities may be due to a compensative phenomenon. Moreover, nitrite overproduction
occurred in patients with chronic total aortic occlusion (TAO group) while its
reduction was observed in severe aortoiliac stenosis (SAS group). Although
antioxidant therapies did not have a consistent effect in some clinical trials for
prevention atherosclerosis complications<sup>[</sup><sup><xref rid="r30" ref-type="bibr">30</xref></sup><sup>]</sup>, this preliminary study offer us a
more comprehensive knowledge about the role of oxidative stress in atherosclerotic
aortas in human beings.</p><table-wrap id="t3" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup width="50%" span="1"><col span="1"/><col span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors' roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">MLL</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; conception and
design study; manuscript redaction or critical review of its
content; realization of operations and/or trials; statistical
analysis; final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CCC</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ABK</td><td align="left" rowspan="1" colspan="1">Analysis and/or data interpretation; final manuscript
approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ANK</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final manuscript approval</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NA</td><td align="left" rowspan="1" colspan="1">Manuscript redaction or critical review of its content;
final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn><fn fn-type="other"><p>This study was carried out at the Department of Vascular Surgery, Santa Casa de
Porto Alegre, RS, Brazil.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn></fn-group><ref-list><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norgren</surname><given-names>L</given-names></name><name><surname>Hiatt</surname><given-names>WR</given-names></name><name><surname>Dormandy</surname><given-names>JA</given-names></name><name><surname>Nehler</surname><given-names>MR</given-names></name><name><surname>Harris</surname><given-names>KA</given-names></name><name><surname>Fowkes</surname><given-names>FG</given-names></name><collab>TASC II Working Group</collab></person-group><article-title>Inter-Society Consensus for the Management of Peripheral Arterial
Disease (TASC II)</article-title><source>J Vasc Surg</source><year>2007</year><volume>45</volume><issue>Suppl S</issue><fpage>5</fpage><lpage>67</lpage></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>ML</given-names></name><name><surname>Deibler</surname><given-names>L</given-names></name><name><surname>Erling</surname><given-names>N</given-names><suffix>Jr</suffix></name><name><surname>Lichtenfels</surname><given-names>E</given-names></name><name><surname>Aerts</surname><given-names>N</given-names></name></person-group><article-title>Surgical treatment of chronic aortoiliac
occlusion</article-title><source>J Vasc Bras</source><year>2015</year><volume>14</volume><issue>1</issue><fpage>29</fpage><lpage>36</lpage></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haidari</surname><given-names>M</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Gangehei</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Cybulsky</surname><given-names>MI</given-names></name></person-group><article-title>Increased oxidative stress in atherosclerosis-predisposed regions
of the mouse aorta</article-title><source>Life Sci</source><year>2010</year><volume>87</volume><issue>3-4</issue><fpage>100</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">20553954</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy Chowdhury</surname><given-names>SK</given-names></name><name><surname>Sangle</surname><given-names>GV</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Stelmack</surname><given-names>GL</given-names></name><name><surname>Halayko</surname><given-names>AJ</given-names></name><name><surname>Shen</surname><given-names>GX</given-names></name></person-group><article-title>Effects of extensively oxidized low-density lipoprotein on
mitochondrial function and reactive oxygen species in porcine aoric
endothelial cells</article-title><source>Am J Physiol Endocrinol Metab</source><year>2010</year><volume>298</volume><issue>1</issue><fpage>E89</fpage><lpage>E98</lpage><pub-id pub-id-type="pmid">19843872</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto</surname><given-names>ME</given-names></name><name><surname>Soria-Castro</surname><given-names>E</given-names></name><name><surname>Lans</surname><given-names>VG</given-names></name><name><surname>Ontiveros</surname><given-names>EM</given-names></name><name><surname>Mej&#x000ed;a</surname><given-names>BI</given-names></name><name><surname>Hernandez</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Analysis of oxidative stress enzymes and structural and
functional proteins on human aortic tissue from different
aortopathies</article-title><source>Oxid Med Cell Longev</source><year>2014</year><volume>2014</volume><fpage>760694</fpage><lpage>760694</lpage><pub-id pub-id-type="pmid">25101153</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>U</given-names></name><name><surname>Jialal</surname><given-names>I</given-names></name></person-group><article-title>Oxidative stress and atherosclerosis</article-title><source>Pathophysiology</source><year>2006</year><volume>13</volume><issue>3</issue><fpage>129</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">16757157</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>AE</given-names></name><name><surname>Melnikov</surname><given-names>P</given-names></name><name><surname>C&#x000f4;nsolo</surname><given-names>LZ</given-names></name></person-group><article-title>Oxidative stress in coronary artery bypass
surgery</article-title><source>Rev Bras Cir Cardiovasc</source><year>2015</year><volume>30</volume><issue>4</issue><fpage>417</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">27163415</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Lv</surname><given-names>Z</given-names></name></person-group><article-title>Beneficial effects of hyperosmotic perfusion in the myocardium
after ischemia/reperfusion injury in isolated rat hearts</article-title><source>Rev Bras Cir Cardiovasc</source><year>2013</year><volume>28</volume><issue>1</issue><fpage>54</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">23739933</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pari</surname><given-names>L</given-names></name><name><surname>Monisha</surname><given-names>P</given-names></name><name><surname>Mohamed Jalaludeen</surname><given-names>A</given-names></name></person-group><article-title>Beneficial role of diosgenin on oxidative stress in aorta of
streptozotocin induced diabetic rats</article-title><source>Eur J Pharmacol</source><year>2012</year><volume>691</volume><issue>1-3</issue><fpage>143</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">22771295</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yajima</surname><given-names>N</given-names></name><name><surname>Masuda</surname><given-names>M</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>N</given-names></name><name><surname>Chien</surname><given-names>S</given-names></name><name><surname>Shyy</surname><given-names>JY</given-names></name></person-group><article-title>Oxidative stress is involved in the development of experimental
abdominal aortic aneurysm: a study of the transcription profile with
complementary DNA microarray</article-title><source>J Vasc Surg</source><year>2002</year><volume>36</volume><issue>2</issue><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">12170221</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>MF</given-names></name><name><surname>Jing</surname><given-names>ZP</given-names></name><name><surname>Bao</surname><given-names>JM</given-names></name><name><surname>Zhao</surname><given-names>ZQ</given-names></name><name><surname>Mei</surname><given-names>ZJ</given-names></name><name><surname>Lu</surname><given-names>QS</given-names></name><etal/></person-group><article-title>Role of nitric oxide and inducible nitric oxide synthase in human
abdominal aortic aneurysms: a preliminary study</article-title><source>Chin Med J (Engl)</source><year>2006</year><volume>119</volume><issue>4</issue><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">16537027</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sart&#x000f3;rio</surname><given-names>CL</given-names></name><name><surname>Fraccarollo</surname><given-names>D</given-names></name><name><surname>Galuppo</surname><given-names>P</given-names></name><name><surname>Leutke</surname><given-names>M</given-names></name><name><surname>Ertl</surname><given-names>G</given-names></name><name><surname>Stefanon</surname><given-names>I</given-names></name><etal/></person-group><article-title>Mineralocorticoid receptor blockade improve vasomotor dysfunction
and vascular oxidative stress after myocardial infarction</article-title><source>Hypertension</source><year>2007</year><volume>50</volume><issue>5</issue><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">17846350</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBel</surname><given-names>CP</given-names></name><name><surname>Ischiropoulos</surname><given-names>H</given-names></name><name><surname>Bondy</surname><given-names>SC</given-names></name></person-group><article-title>Evaluation of the probe 2',7'-dichlorofluorescin as an indicator
of reactive oxygen species formation and oxidative stress</article-title><source>Chem Res Toxicol</source><year>1992</year><volume>5</volume><issue>2</issue><fpage>227</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">1322737</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Sowers</surname><given-names>JR</given-names></name><name><surname>Nistala</surname><given-names>R</given-names></name><name><surname>Gong</surname><given-names>H</given-names></name><name><surname>Uptergrove</surname><given-names>GM</given-names></name><name><surname>Clark</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Angiotensin II-induced NADPH oxidase activation impairs insulin
signaling in skeletal muscle cells</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><issue>46</issue><fpage>35137</fpage><lpage>35146</lpage><pub-id pub-id-type="pmid">16982630</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marklund</surname><given-names>SL</given-names></name></person-group><article-title>Superoxide dismutase isoenzymes in tissues and plasma from New
Zealand black mice, nude mice and normal BALB/c mice</article-title><source>Mutat Res</source><year>1985</year><volume>148</volume><issue>1-2</issue><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">3969077</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aebi</surname><given-names>H</given-names></name></person-group><article-title>Catalase in vitro</article-title><source>Methods Enzymol</source><year>1984</year><volume>105</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">6727660</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granger</surname><given-names>DL</given-names></name><name><surname>Anstey</surname><given-names>NM</given-names></name><name><surname>Miller</surname><given-names>WC</given-names></name><name><surname>Weinberg</surname><given-names>JB</given-names></name></person-group><article-title>Measuring nitric oxide production in human clinical
studies</article-title><source>Methods Enzymol</source><year>1999</year><volume>301</volume><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">9919553</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowry</surname><given-names>OH</given-names></name><name><surname>Rosebrough</surname><given-names>NJ</given-names></name><name><surname>Farr</surname><given-names>AL</given-names></name><name><surname>Randall</surname><given-names>RJ</given-names></name></person-group><article-title>Protein measurement with the Folin phenol reagent</article-title><source>J Biol Chem</source><year>1951</year><volume>193</volume><issue>1</issue><fpage>265</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">14907713</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>KW</given-names></name><name><surname>Davies</surname><given-names>RS</given-names></name><name><surname>Nightingale</surname><given-names>PG</given-names></name><name><surname>Bradbury</surname><given-names>AW</given-names></name><name><surname>Adam</surname><given-names>DJ</given-names></name></person-group><article-title>Review of direct anatomical open surgical management of
atherosclerotic aorto-iliac occlusive disease</article-title><source>Eur J Endovasc Surg</source><year>2010</year><volume>39</volume><issue>4</issue><fpage>460</fpage><lpage>471</lpage></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raaz</surname><given-names>U</given-names></name><name><surname>Toh</surname><given-names>R</given-names></name><name><surname>Maegdefessel</surname><given-names>L</given-names></name><name><surname>Adam</surname><given-names>M</given-names></name><name><surname>Nakagami</surname><given-names>F</given-names></name><name><surname>Emrich</surname><given-names>FC</given-names></name><etal/></person-group><article-title>Hemodynamic regulation of reactive oxygen species: implications
for vascular diseases</article-title><source>Antioxid Redox Signal</source><year>2014</year><volume>20</volume><issue>6</issue><fpage>914</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">23879326</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>FJ</given-names><suffix>Jr</suffix></name><name><surname>Sharp</surname><given-names>WJ</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Oberley</surname><given-names>LW</given-names></name><name><surname>Oberley</surname><given-names>TD</given-names></name><name><surname>Weintraub</surname><given-names>NL</given-names></name></person-group><article-title>Oxidative stress in human abdominal aortic aneurysms: a potential
mediator of aneurysmal remodeling</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2002</year><volume>22</volume><issue>4</issue><fpage>560</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">11950691</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>W</given-names></name><name><surname>Mactaggart</surname><given-names>J</given-names></name><name><surname>Knispel</surname><given-names>R</given-names></name><name><surname>Worth</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inhibition of reactive oxygen species attenuates aneurysm
formation in a murine model</article-title><source>Atherosclerosis</source><year>2009</year><volume>202</volume><issue>1</issue><fpage>128</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">18502427</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manea</surname><given-names>A</given-names></name><name><surname>Manea</surname><given-names>SA</given-names></name><name><surname>Gan</surname><given-names>AM</given-names></name><name><surname>Constantin</surname><given-names>A</given-names></name><name><surname>Fenyo</surname><given-names>IM</given-names></name><name><surname>Raicu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Human monocytes and macrophages express NADPH oxidase 5; a
potential source of reactive oxygen species in
atherosclerosis</article-title><source>Biochem Biophys Res Commun</source><year>2015</year><volume>461</volume><issue>1</issue><fpage>172</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">25871798</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubick</surname><given-names>MA</given-names></name><name><surname>Keen</surname><given-names>CL</given-names></name><name><surname>DiSilvestro</surname><given-names>RA</given-names></name><name><surname>Eskelson</surname><given-names>CD</given-names></name><name><surname>Ireton</surname><given-names>J</given-names></name><name><surname>Hunter</surname><given-names>GC</given-names></name></person-group><article-title>Antioxidant enzyme activity in human abdominal aortic aneurysmal
and occlusive disease</article-title><source>Proc Soc Exp Biol Med</source><year>1999</year><volume>220</volume><issue>1</issue><fpage>39</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">9893167</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubick</surname><given-names>MA</given-names></name><name><surname>Hunter</surname><given-names>GC</given-names></name><name><surname>Casey</surname><given-names>SM</given-names></name><name><surname>Keen</surname><given-names>CL</given-names></name></person-group><article-title>Aortic ascorbic acid, trace elements, and superoxide dismutase in
human aneurysmal and occlusive disease</article-title><source>Proc Soc Exp Biol Med</source><year>1987</year><volume>184</volume><issue>2</issue><fpage>138</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">3809168</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maiellaro-Rafferty</surname><given-names>K</given-names></name><name><surname>Weiss</surname><given-names>D</given-names></name><name><surname>Joseph</surname><given-names>G</given-names></name><name><surname>Wan</surname><given-names>W</given-names></name><name><surname>Gleason</surname><given-names>RL</given-names></name><name><surname>Taylor</surname><given-names>WR</given-names></name></person-group><article-title>Catalase overexpression in aortic smooth muscle prevents
pathological mechanical changes underlying abdominal aortic aneurysm
formation</article-title><source>Am J Physiol Heart Circ Physiol</source><year>2011</year><volume>301</volume><issue>2</issue><fpage>H355</fpage><lpage>H362</lpage><pub-id pub-id-type="pmid">21551275</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Mozo</surname><given-names>P</given-names></name><name><surname>Madrigal-Matute</surname><given-names>J</given-names></name><name><surname>Martinez-Pinna</surname><given-names>R</given-names></name><name><surname>Blanco-Colio</surname><given-names>LM</given-names></name><name><surname>Lopez</surname><given-names>JA</given-names></name><name><surname>Camafeita</surname><given-names>E</given-names></name><etal/></person-group><article-title>Proteomic analysis of polymorphonuclear neutrophils identifies
catalase as a novel biomaker of abdominal aortic aneurysm: potential
implication of oxidative stress in abdominal aortic aneurysm
progression</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2011</year><volume>31</volume><issue>12</issue><fpage>3011</fpage><lpage>3019</lpage><pub-id pub-id-type="pmid">21940941</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosio</surname><given-names>G</given-names></name><name><surname>Tritto</surname><given-names>I</given-names></name><name><surname>Golino</surname><given-names>P</given-names></name></person-group><article-title>Reactive oxygen metabolites and arterial
thrombosis</article-title><source>Cardiovasc Res</source><year>1997</year><volume>34</volume><issue>3</issue><fpage>445</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">9231027</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnet</surname><given-names>UA</given-names></name><name><surname>McMillan</surname><given-names>A</given-names></name><name><surname>Dinerman</surname><given-names>JL</given-names></name><name><surname>Ballermann</surname><given-names>B</given-names></name><name><surname>Lowenstein</surname><given-names>CJ</given-names></name></person-group><article-title>Regulation of endothelial nitric-oxide synthase during
hypoxia</article-title><source>J Biol Chem</source><year>1996</year><volume>271</volume><issue>25</issue><fpage>15069</fpage><lpage>15073</lpage><pub-id pub-id-type="pmid">8663208</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fearon</surname><given-names>IM</given-names></name><name><surname>Faux</surname><given-names>SP</given-names></name></person-group><article-title>Oxidative stress and cardiovascular disease: novel tools give
(free) radical insight</article-title><source>J Mol Cell Cardiol</source><year>2009</year><volume>47</volume><issue>3</issue><fpage>372</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">19481547</pub-id></element-citation></ref></ref-list></back></article>